How to Buy Pacira Biosciences Stock

Pacira Biosciences Inc

Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health.

Pacira Biosciences stock last closed at $36.46, down 0.08% from the previous day, and has increased 51.16% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 1.51 percentage points. Pacira Biosciences stock is currently +93.94% from its 52-week low of $18.80, and -0.56% from its 52-week high of $36.67.

There are currently 40.09M PCRX shares outstanding. The market capitalization of PCRX is $1.46B. In the past 24 hours, 945,000 PCRX shares were traded.

How to Buy Pacira Biosciences Stock

Not sure how to invest in Pacira Biosciences stock? Here's how.

  1. Figure out where to buy Pacira Biosciences stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Pacira Biosciences stock.
  2. Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your investment account: Pick your payment method and add your information.
  4. Analyze Pacira Biosciences stock: The Pacira Biosciences ticker symbol is PCRX. Is Pacira Biosciences stock a good investment? Should you buy shares of PCRX? How do PCRX's underlying business fundamentals look? Do top analysts think Pacira Biosciences is a good buy? Why has PCRX's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if PCRX is a good stock to buy).
  5. Execute your PCRX buy order: Decide if you will purchase PCRX shares at the current market price or use a limit order to buy PCRX stock at a given price.
  6. Monitor your PCRX position: Create a watchlist to important updates regarding your investment in Pacira Biosciences shares.

Step 1: Figure out where to buy Pacira Biosciences stock

You need an online brokerage account to access the NASDAQ market and buy PCRX stock.

A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best online stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world financial markets: From Tech to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've selected the right brokerage, it's time to fill out some personal info so you can invest in PCRX stock today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to create a new brokerage account.
  1. Submit your application by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you have finished signing up on stock market app, you need to deposit funds:

Watch the video below for more details transferring money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Pacira Biosciences stock

Once you have chosen the best place to buy Pacira Biosciences stock, it's crucial to analyze their stock prior to buying, so you can wrap your head around the risk and opportunity.

Pacira Biosciences shares data

PCRX Price
$36.46
1w %
0.16%
1y %
51.16%
5y %
-35.82%
P/E
38.38x
P/B
2.05x
P/S
1.96x
PEG
0.58x
Revenue
$743.30M
Earnings
$37.73M
Fore. Rev. Growth
5.06%
Fore. Earn. Growth
66.2%
Market Cap
$1.46B
Next Earnings
N/A
Next Dividend
N/A

Pacira Biosciences Due Diligence Checks

WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.

You can view all of the due diligence checks on PCRX's stock page.

Is PCRX stock properly valued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PCRX's true value.

Using relative valuations metrics:

  • PCRX may be undervalued based on its P/E ratio of 38.38x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 69x
  • PCRX could be undervalued based on its P/B ratio of 2.05x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.55x
  • PCRX may be undervalued based on its PEG ratio of 0.58x

You can access additional valuation research on PCRX's stock here.

A look at PCRX Cashflows and Balance Sheet

Passed Financial Due Diligence Checks:

  • There are more short-term assets than short-term liabilities on the PCRX balance sheet.
  • There are more short-term assets than long-term liabilities on the PCRX balance sheet.
  • PCRX profit margin has gone up from 3% to 5.1% in the past year.
  • Total PCRX debt is lower than 5 years ago, relative to shareholder equity.
  • PCRX's operating cash flow of $176.90M allows it to safely service it's debt of $340.28M.

Failed Financial Due Diligence Checks:

  • PCRX earnings of $51.04M is not sufficient to cover its interest payments.
  • PCRX has a relatively high debt to equity ratio of 0.69.

Is it a good time to buy Pacira Biosciences stock, according to Wall Street analysts?

Out of 7 Wall Street analysts who monitor PCRX, the consensus analyst rating on PCRX is a Hold

Please note that analyst ratings are not stock recommendations, nor are they investment advice.

Latest PCRX Analyst Forecasts

Serge Belanger, a top 2% analyst from Needham downgrades PCRX to a hold rating, on Oct 8, 2026.

Les Sulewski, a top 37% analyst from Truist Securities maintains PCRX with a strong buy rating and raises their PCRX price target from $30.00 to $31.00, on Oct 7, 2026.

Daniel Clark, a top 31% analyst from Leerink Partners initiates coverage on PCRX with a hold rating and announces their PCRX price target of $28.00, on Sep 9, 2026.

You can dive deeper into what analysts are projecting on the Pacira Biosciences stock forecast page.

PCRX Trading Indicators

SMA10
36.42
SMA20
36.39
SMA50
30.79
SMA100
28.03
SMA200
25.49
MACD
1.5
MACD Signal
1.89
MACD Histogram
-0.4
RSI
82.71
Stochastic %K
88.32
Stochastic %D
86.73
StochRSI %K
36.94
StochRSI %D
34.76

PCRX Growth Numbers

Last year, PCRX earnings were $37.73M. In the past 5 year, PCRX's earnings have gone up by -7.33% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of -4.65%.

Last year, PCRX revenue was $743.30M. Over the last five year, PCRX's revenue has grown by 7.69% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 8.2%.

You can research PCRX's earnings and revenue performance here.

Who is buying/selling PCRX?

Over the last year, insiders at PCRX have sold more shares than they have bought.

Shawn Cross, CFO of PCRX, was the latest PCRX insider to sell. They sold $347,160.60 worth of PCRX stock on Oct 30, 2026.

Learn more about who owns PCRX stock here.

Can I get consistent income from PCRX stock?

No, Pacira Biosciences doesn't provide an income stream by paying out dividends.

What others are saying about PCRX

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Execute your PCRX buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are usually fine for most investors.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at a specific dollar amount, use a limit order.

Hit the Open Trade button and your broker will place your order.

If you want more help buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Monitor your PCRX position

Now that you own some PCRX stock, you'll want to keep up with your company.

Make a watchlist to get the latest updates about your PCRX stock.

PCRX Feed

How to Buy Stock in Pacira Biosciences

To reiterate, here are the 6 steps for buying Pacira Biosciences stock:

  1. Figure out where to buy Pacira Biosciences stock
  2. Open a brokerage account
  3. Deposit funds into your investment account
  4. Analyze Pacira Biosciences stock
  5. Execute your PCRX buy order
  6. Monitor your PCRX position

If you require a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to watch your investment in Pacira Biosciences, click below.

NASDAQ: PCRX
$36.46-0.03 (-0.08%)
Updated Nov 11, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: PCRX
$36.46-0.03 (-0.08%)
Updated Nov 11, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Pacira Biosciences share?

As of Nov 11, 2026, it costs $36.46 to buy one share of Pacira Biosciences stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.274 shares of PCRX.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Pacira Biosciences stock?

According to 7 Wall Street analysts who monitor Pacira Biosciences, their consensus recommendation is to hold Pacira Biosciences stock.

What is the best way to buy Pacira Biosciences stock?

One way to place an order for Pacira Biosciences stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.